Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,976.00
Bid: 1,988.00
Ask: 1,989.00
Change: -8.00 (-0.40%)
Spread: 1.00 (0.05%)
Open: 1,988.00
High: 2,008.00
Low: 1,975.00
Prev. Close: 1,984.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tuesday broker round-up

Tue, 10th Nov 2020 13:17

(Sharecast News) - On the Beach: Citigroup downgrades to neutral with a target price of 370p.



Ultra Electronics Holdings: Berenberg reiterates buy with a target price of 2,600p.

Polymetal International: Berenberg reiterates buy with a target price of 2,560p.

James Fisher and Sons: Canaccord upgrades to buy with a target price of 1,200p.

Taylor Wimpey: Canaccord reiterates buy with a target price of 165p.

Yellow Cake: Canaccord initiates at buy with a target price of 290p.

RSA: Citigroup downgrades to neutral with a target price of 685p.

Clinigen: Peel Hunt reiterates hold with a target price of 820p.

Energean: Peel Hunt reiterates buy with a target price of 1,000p.

Beazley: Barclays initiates at overweight with a target price of 391p.

Hikma Pharmaceuticals: Barclays reiterates overweight with a target price of 2,950p.

Ferguson: Deutsche Bank reiterates buy with a target price of 10,100p.

AVEVA: Credit Suisse reiterates neutral with a target price of 4,690p.

S4: Credit Suisse reiterates outperform with a target price of 500p.
More News
10 Nov 2020 09:44

UK BROKER RATINGS SUMMARY: Investec Cuts Barclays; Goldman Raises Next

UK BROKER RATINGS SUMMARY: Investec Cuts Barclays; Goldman Raises Next

Read more
5 Nov 2020 10:44

TOP NEWS: Hikma Lifts Annual Guidance; Launches Generic Drug In US

TOP NEWS: Hikma Lifts Annual Guidance; Launches Generic Drug In US

Read more
5 Nov 2020 09:24

LONDON MARKET OPEN: Pound Keeps Lid On FTSE 100 As BoE Boosts Support

LONDON MARKET OPEN: Pound Keeps Lid On FTSE 100 As BoE Boosts Support

Read more
5 Nov 2020 09:15

Hikma raises FY guidance for generics unit following positive H1 momentum

(Sharecast News) - Pharmaceutical company Hikma said on Thursday that the group as a whole was "performing well" and had maintained the positive momentum seen in the first half, leading it to reiterate guidance for one unit and raise it on another.

Read more
4 Nov 2020 17:06

LONDON MARKET CLOSE: Strong End To Choppy Session On Tight US Poll

LONDON MARKET CLOSE: Strong End To Choppy Session On Tight US Poll

Read more
4 Nov 2020 12:12

LONDON MARKET MIDDAY: Stocks In Europe Shake Off US Poll Uncertainty

LONDON MARKET MIDDAY: Stocks In Europe Shake Off US Poll Uncertainty

Read more
4 Nov 2020 10:38

UK WINNERS & LOSERS SUMMARY: Pharmaceutical Firms Rally

UK WINNERS & LOSERS SUMMARY: Pharmaceutical Firms Rally

Read more
29 Oct 2020 16:02

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
20 Oct 2020 11:03

Hikma Pharmaceuticals Expands US Collaboration With Arecor

Hikma Pharmaceuticals Expands US Collaboration With Arecor

Read more
1 Oct 2020 09:42

UK BROKER RATINGS SUMMARY: Goldman Raises Coca-Cola HBC And Cuts DCC

UK BROKER RATINGS SUMMARY: Goldman Raises Coca-Cola HBC And Cuts DCC

Read more
22 Sep 2020 19:34

IN BRIEF: Vectura Notes Hikma's Advair US Regulatory Setback

IN BRIEF: Vectura Notes Hikma's Advair US Regulatory Setback

Read more
22 Sep 2020 17:04

LONDON MARKET CLOSE: Stocks Rebound Slightly As Covid-19 Fears Remain

LONDON MARKET CLOSE: Stocks Rebound Slightly As Covid-19 Fears Remain

Read more
22 Sep 2020 10:37

UK WINNERS & LOSERS SUMMARY: Beazley's Virus Claims Estimate Doubles

UK WINNERS & LOSERS SUMMARY: Beazley's Virus Claims Estimate Doubles

Read more
22 Sep 2020 08:48

Hikma Expects To Gain FDA Approval For Advair Diskus In Early 2021

Hikma Expects To Gain FDA Approval For Advair Diskus In Early 2021

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.